← SynDRA
FULACIMSTAT
SynDRA canonical compound SYN0039694 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CTRL |
| Mechanism of action | chymotrypsin inhibitor |
| Indication | diabetes mellitus |
| Disease area | endocrinology |
All known targets
Mechanisms of action (all sources)
- CMA1 INHIBITOR
- Chymase inhibitor
- chymotrypsin inhibitor
Drug classes
Cross-references
Synonyms
- BAY1142524
- BAY-1142524
- UNII-VIR72PP4ZU
- VIR72PP4ZU
- 1-yl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
- 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-
- 2,4-dioxo-3-[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-
- Fulacimstat [INN]
- Fulacimstat(BAY 1142524)
- CHEMBL4297596
- SCHEMBL16701233
- EX-A2732
- DB15085
- HY-109059
- CS-0032987
- (R)-1-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)-2,4-dioxo-3-(4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
- 1-(2,3-Dihydro-3-methyl-2-oxo-6-benzoxazolyl)-3-((1R)-2,3-dihydro-4-(trifluoromethyl)-1H-inden-1-yl)-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinecarboxylic acid
- 1-(3-methyl-2-oxo-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]pyrimidine-5-carboxylic acid
- 1-(3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-((1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl)-1,2,3,4-tetrahydro-5-pyrimidinecarboxylic acid
- 1-(3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
- 5-Pyrimidinecarboxylic acid, 1-(2,3-dihydro-3-methyl-2-oxo-6-benzoxazolyl)-3-((1R)-2,3-dihydro-4-(trifluoromethyl)-1H-inden-1-yl)-1,2,3,4-tetrahydro-2,4-dioxo-
- BAY 1142524
- fulacimstatum
- RefChem:141620
- FULACIMSTAT [INN]
- A1IJ2
- Fulacimstat; BAY1142524
- orb1296254
- SCHEMBL29361756
- SCHEMBL29644538
- C23H16F3N3O6
- GLXC-20297
- MFCD31746878
- AC-35608
- MS-29052
- G16473
Look up FULACIMSTAT in the interactive SynDRA portal →